Literature DB >> 24407718

Renal atrophy after ischemia-reperfusion injury depends on massive tubular apoptosis induced by TNFα in the later phase.

Takaomi Adachi1, Noriyuki Sugiyama, Hideo Yagita, Takahiko Yokoyama.   

Abstract

Recent studies have suggested that acute kidney injury (AKI) develops into chronic kidney disease (CKD). However, a mechanism for disease progression from AKI to CKD has not been established. We developed two ischemia-reperfusion injury (IRI) mouse models, a repaired kidney model and an atrophic kidney model, and studied the mechanisms of renal atrophy after IRI by comparing the two models. We found that renal atrophy after IRI depended on tubular apoptosis at 14 days after IRI. Moreover, we found that Tnfα and FasL mRNA were synchronously expressed at the time of tubular apoptosis. To elucidate the relationship between tubular apoptosis and apoptotic ligands, we administered TNFα and FasL neutralizing antibodies according to the time of tubular apoptosis. TNFα blockade significantly repressed tubular apoptosis, resulting in the prevention of renal atrophy. FasL blockade could not repress tubular apoptosis, resulting in renal atrophy. We also found that TNF receptors were expressed in the kidney at 14 days after IRI, but Fas receptor was not. We concluded that renal atrophy after IRI depends on tubular apoptosis induced by the TNFα signaling pathway in the later phase of renal IRI, and that TNFα blockade could be a potential new therapeutic approach for improving renal prognosis after AKI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24407718     DOI: 10.1007/s00795-013-0067-3

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  37 in total

Review 1.  Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls.

Authors:  Léia C R Silva; Luciena C M Ortigosa; Gil Benard
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

2.  Induction of apoptosis in ischemia-reperfusion model of mouse kidney: possible involvement of Fas.

Authors:  S Nogae; M Miyazaki; N Kobayashi; T Saito; K Abe; H Saito; P K Nakane; Y Nakanishi; T Koji
Journal:  J Am Soc Nephrol       Date:  1998-04       Impact factor: 10.121

3.  Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death.

Authors:  Kazuhiko Tsuruya; Toshiharu Ninomiya; Masanori Tokumoto; Makoto Hirakawa; Kohsuke Masutani; Masatomo Taniguchi; Kyoichi Fukuda; Hidetoshi Kanai; Kenji Kishihara; Hideki Hirakata; Mitsuo Iida
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

4.  Renal tubular Fas ligand mediates fratricide in cisplatin-induced acute kidney failure.

Authors:  Andreas Linkermann; Nina Himmerkus; Lars Rölver; Kirsten A Keyser; Philip Steen; Jan-Hinrich Bräsen; Markus Bleich; Ulrich Kunzendorf; Stefan Krautwald
Journal:  Kidney Int       Date:  2010-09-01       Impact factor: 10.612

5.  Enhanced recovery from postischemic acute renal failure. Micropuncture studies in the rat.

Authors:  W F Finn
Journal:  Circ Res       Date:  1980-03       Impact factor: 17.367

6.  Sustained cell proliferation of renal epithelial cells in mice with inv mutation.

Authors:  Noriyuki Sugiyama; Takahiko Yokoyama
Journal:  Genes Cells       Date:  2006-10       Impact factor: 1.891

7.  TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury.

Authors:  Rafia S Al-Lamki; Jun Wang; Peter Vandenabeele; J Andrew Bradley; Sathia Thiru; Dianghong Luo; Wang Min; Jordan S Pober; John R Bradley
Journal:  FASEB J       Date:  2005-10       Impact factor: 5.191

Review 8.  Role of apoptosis in hypoxic/ischemic damage in the kidney.

Authors:  Pothana Saikumar; Manjeri A Venkatachalam
Journal:  Semin Nephrol       Date:  2003-11       Impact factor: 5.299

9.  Apoptosis and cell desquamation in repair process of ischemic tubular necrosis.

Authors:  A Shimizu; N Yamanaka
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1993

10.  Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.

Authors:  Juan J Gómez-Reino; Loreto Carmona; Vicente Rodríguez Valverde; Emilio Martín Mola; Maria Dolores Montero
Journal:  Arthritis Rheum       Date:  2003-08
View more
  10 in total

1.  Effects of sevoflurane on NF-кB and TNF-α expression in renal ischemia-reperfusion diabetic rats.

Authors:  Yu Zhang; Fang Hu; Jianghua Wen; Xiaohong Wei; Yingjuan Zeng; Ying Sun; Shunkui Luo; Liao Sun
Journal:  Inflamm Res       Date:  2017-07-06       Impact factor: 4.575

2.  Quantified kidney echogenicity in mice with renal ischemia reperfusion injury: evaluation as a noninvasive biomarker of acute kidney injury.

Authors:  Shinya Murata; Noriyuki Sugiyama; Kentaro Maemura; Yoshinori Otsuki
Journal:  Med Mol Morphol       Date:  2017-04-05       Impact factor: 2.309

3.  Quantitative evaluation of renal parenchymal perfusion using contrast-enhanced ultrasonography in renal ischemia-reperfusion injury in dogs.

Authors:  Gahyun Lee; Sunghoon Jeon; Sang-Kwon Lee; Byunggyu Cheon; Sohyeon Moon; Jun-Gyu Park; Kyoung-Oh Cho; Jihye Choi
Journal:  J Vet Sci       Date:  2017-12-31       Impact factor: 1.672

Review 4.  Food strategies of renal atrophy based on Avicenna and conventional medicine.

Authors:  Marjan Mahjour; Arash Khoushabi; Maryam Miri Ghale Novi; Zohre Feyzabadi
Journal:  J Tradit Complement Med       Date:  2017-01-10

5.  Anti-high mobility group box-1 (HMGB1) antibody attenuates kidney damage following experimental crush injury and the possible role of the tumor necrosis factor-α and c-Jun N-terminal kinase pathway.

Authors:  Bin-Fei Zhang; Peng-Fei Wang; Yu-Xuan Cong; Jin-Lai Lei; Hu Wang; Hai Huang; Shuang Han; Yan Zhuang
Journal:  J Orthop Surg Res       Date:  2017-07-12       Impact factor: 2.359

6.  Histological characteristics of Acute Tubular Injury during Delayed Graft Function predict renal function after renal transplantation.

Authors:  Tobias T Pieters; Lucas L Falke; Tri Q Nguyen; Marianne C Verhaar; Sandrine Florquin; Frederike J Bemelman; Jesper Kers; Thomas Vanhove; Dirk Kuypers; Roel Goldschmeding; Maarten B Rookmaaker
Journal:  Physiol Rep       Date:  2019-03

7.  Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis.

Authors:  Jamie S Lin; Omar Mamlouk; Umut Selamet; Amanda Tchakarov; William F Glass; Rahul A Sheth; Rachel M Layman; Ramona Dadu; Noha Abdelwahab; Maen Abdelrahim; Adi Diab; Cassian Yee; Ala Abudayyeh
Journal:  Oncoimmunology       Date:  2021-02-02       Impact factor: 8.110

8.  Geroprotective effects of Alzheimer's disease drug candidates.

Authors:  Devin Kepchia; Antonio Currais; Richard Dargusch; Kim Finley; David Schubert; Pamela Maher
Journal:  Aging (Albany NY)       Date:  2021-02-06       Impact factor: 5.682

9.  Kidney-specific Sonoporation-mediated Gene Transfer.

Authors:  Ryo Ishida; Daisuke Kami; Tetsuro Kusaba; Yuhei Kirita; Tsunao Kishida; Osam Mazda; Takaomi Adachi; Satoshi Gojo
Journal:  Mol Ther       Date:  2015-09-30       Impact factor: 11.454

10.  Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage.

Authors:  Zhibo Gai; Lei Chu; Zhenqiang Xu; Xiaoming Song; Dongfeng Sun; Gerd A Kullak-Ublick
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.